Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
U2AF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CHIC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLE3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTC37 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP1R26-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
FUBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM120A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EMB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
XIAP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRP9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABHD17B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUP50 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP9B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SARAF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPL39 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HBS1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LSM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GTF2H2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBPJ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on